Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.
Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
JACC Heart Fail. 2023 Jun;11(6):678-688. doi: 10.1016/j.jchf.2023.01.006. Epub 2023 Mar 1.
Heart failure (HF) is a major complication in patients with hypertension.
This study aimed to investigate the extent to which joint risk factor control could attenuate hypertension-related excess risk of HF.
The study included a total of 75,293 participants with diagnosed hypertension from the UK Biobank and matched with 256,619 nonhypertensive control subjects, followed up until May 31, 2021. The degree of joint risk factor control was assessed on the basis of the major cardiovascular risk factors, including blood pressure, body mass index, low-density lipoprotein cholesterol, hemoglobin A1c, albuminuria, smoking, and physical activity. The Cox proportional hazards models were used to estimate associations between the degree of risk factor control and risk of HF.
Among hypertensive patients, joint risk factor control showed an association with a stepwise reduction of incident HF risk. Each additional risk factor control was related to a 20% lower risk, and the optimal risk factor control (controlling ≥6 risk factors) was associated with a 62% lower risk (HR: 0.38; 95% CI: 0.31-0.45). In addition, the study found that the hypertension-related excess risk of HF among participants jointly controlling ≥6 risk factors were even lower than in nonhypertensive control subjects (HR: 0.79; 95% CI: 0.67-0.94). The protective associations of joint risk factor control and risk of incident HF were broadly stronger among men than women and among medication users than nonusers (P for interaction < 0.05).
The joint risk factor control is associated with a lower risk of incident HF in an accumulative and sex-specific manner. Optimal risk factor control may eliminate hypertension-related excess risk of HF.
心力衰竭(HF)是高血压患者的主要并发症。
本研究旨在探讨联合危险因素控制在多大程度上可以减轻高血压相关的 HF 超额风险。
该研究共纳入了来自英国生物库的 75293 名确诊高血压患者和 256619 名非高血压对照者,随访至 2021 年 5 月 31 日。主要心血管危险因素(包括血压、体重指数、低密度脂蛋白胆固醇、糖化血红蛋白、蛋白尿、吸烟和体力活动)的控制程度来评估联合危险因素控制程度。使用 Cox 比例风险模型估计危险因素控制程度与 HF 风险之间的关联。
在高血压患者中,联合危险因素控制与 HF 事件风险的逐步降低有关。每增加一个危险因素的控制,风险降低 20%,最佳危险因素控制(控制≥6 个危险因素)与风险降低 62%相关(HR:0.38;95%CI:0.31-0.45)。此外,研究还发现,在共同控制≥6 个危险因素的参与者中,HF 的高血压相关超额风险甚至低于非高血压对照者(HR:0.79;95%CI:0.67-0.94)。联合危险因素控制与 HF 事件风险之间的保护关联在男性中比女性中更强,在药物使用者中比非使用者中更强(P 交互<0.05)。
联合危险因素控制与 HF 事件风险呈累积性和性别特异性降低相关。最佳危险因素控制可能消除高血压相关的 HF 超额风险。